No Picture
Trading Ideas

Gilead's shares rise on report of experimental drug's promise in COVID-19

There are currently no approved treatments or vaccines for the novel coronavirus, which has infected 2.18 million globally, according to a Reuters tally, and remdesivir is one of the treatments that has captured investor attention. Gilead said the totality of the data from the trial needed to be analyzed, and expects to report results from a study in severe COVID-19 patients at the end of the month, and data from other trials in May. The report said the University of Chicago Medicine Hospital was seeing rapid recoveries in fever and respiratory symptoms in patients with severe COVID-19 in …read more […]

No Picture
Trading Ideas

Needham: 3 Top-Notch Stocks to Buy for a Volatile 2020

The stock market is currently caught in a somewhat volatile trading range. The news headlines are far from pretty – the ranks of newly unemployed jumped to 22 million in the U.S. since policymakers are keeping people home to stem new coronavirus infections. Economic growth came to a standstill to end the first quarter, and start the second.But there are pockets of strength, and will be more in the coming months. Once the economy gets to 2021, the year-over-year trends in next year’s first and second quarters could be eye-popping. Healthcare is holding up very well for obvious reasons. Technology …read more […]